Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SIBN · against 466 other Healthcare companies of similar size
Ranked #318 of 467 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score150 peers with a valuation score of 0–9, including SIBN · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | SIBN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 457 reported | -1.4% | 1.3% | 37% | 30% | |
| EBITDA yieldHigher is better · 472 reported | -1.2% | 4.2% | 29% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -0.4% | -2.6% | 60% | 20% | |
| Book yieldHigher is better · 463 reported | 17.2% | 41.4% | 18% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 318 | 730M USD | 8 | 11 | |
| 318 | 2.0B USD | 8 | 26 | |
| 318 | 2.0B USD | 8 | 53 | |
| 318 | 1.2B USD | 8 | 40 | |
| 318 | 1.1B USD | 8 | 50 | |
| 318 | 673M USD | 8 | 35 | |
| 318 | 1.2B USD | 8 | 21 | |
| 318 | 1.3B USD | 8 | 33 | |
| 318 | 588M USD | 8 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score